Glycemic Efficacy of Canagliflozin (CANA) by Baseline A1C and Known Duration of Type 2 Diabetes Mellitus (T2DM)

✍ Scribed by Leiter, Lawrence A.; Blonde, Lawrence; Wilding, John; Cerdas, Sonia; Tong, Cindy; Yee, Jacqueline; Meininger, Gary

• Book ID: 126953675
• Publisher: Canadian Diabetes Association
• Year: 2014
• Tongue: English
• Weight: 56 KB
• Volume: 38
• Category: Article
• ISSN: 1499-2671
• DOI: 10.1016/j.jcjd.2014.07.124